Request for Covid-19 Impact Assessment of this Report
The United States Non-animal Type Hard Capsules market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Non-animal Type Hard Capsules market, reaching US$ million by the year 2028. As for the Europe Non-animal Type Hard Capsules landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Non-animal Type Hard Capsules players cover Lonza, ACG Associated Capsules, JC Biological Technology, and CapsCanada, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-animal Type Hard Capsules market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Type I
00E
0E
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Pharmaceutical
Nutraceutical
Cosmetics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Lonza
ACG Associated Capsules
JC Biological Technology
CapsCanada
Medicaps
Qualicaps (Mitsubishi Chemical)
Patheon (Banner Pharmacaps)
Roxlor
Sunil Healthcare
Arab-Caps
Jedco International Pharmaceutical
Pharco
ACPL
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Non-animal Type Hard Capsules Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Non-animal Type Hard Capsules by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Non-animal Type Hard Capsules by Country/Region, 2017, 2022 & 2028
2.2 Non-animal Type Hard Capsules Segment by Type
2.2.1 Type I
2.2.2 00E
2.2.3 0E
2.3 Non-animal Type Hard Capsules Sales by Type
2.3.1 Global Non-animal Type Hard Capsules Sales Market Share by Type (2017-2022)
2.3.2 Global Non-animal Type Hard Capsules Revenue and Market Share by Type (2017-2022)
2.3.3 Global Non-animal Type Hard Capsules Sale Price by Type (2017-2022)
2.4 Non-animal Type Hard Capsules Segment by Application
2.4.1 Pharmaceutical
2.4.2 Nutraceutical
2.4.3 Cosmetics
2.5 Non-animal Type Hard Capsules Sales by Application
2.5.1 Global Non-animal Type Hard Capsules Sale Market Share by Application (2017-2022)
2.5.2 Global Non-animal Type Hard Capsules Revenue and Market Share by Application (2017-2022)
2.5.3 Global Non-animal Type Hard Capsules Sale Price by Application (2017-2022)
3 Global Non-animal Type Hard Capsules by Company
3.1 Global Non-animal Type Hard Capsules Breakdown Data by Company
3.1.1 Global Non-animal Type Hard Capsules Annual Sales by Company (2020-2022)
3.1.2 Global Non-animal Type Hard Capsules Sales Market Share by Company (2020-2022)
3.2 Global Non-animal Type Hard Capsules Annual Revenue by Company (2020-2022)
3.2.1 Global Non-animal Type Hard Capsules Revenue by Company (2020-2022)
3.2.2 Global Non-animal Type Hard Capsules Revenue Market Share by Company (2020-2022)
3.3 Global Non-animal Type Hard Capsules Sale Price by Company
3.4 Key Manufacturers Non-animal Type Hard Capsules Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-animal Type Hard Capsules Product Location Distribution
3.4.2 Players Non-animal Type Hard Capsules Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Non-animal Type Hard Capsules by Geographic Region
4.1 World Historic Non-animal Type Hard Capsules Market Size by Geographic Region (2017-2022)
4.1.1 Global Non-animal Type Hard Capsules Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Non-animal Type Hard Capsules Annual Revenue by Geographic Region
4.2 World Historic Non-animal Type Hard Capsules Market Size by Country/Region (2017-2022)
4.2.1 Global Non-animal Type Hard Capsules Annual Sales by Country/Region (2017-2022)
4.2.2 Global Non-animal Type Hard Capsules Annual Revenue by Country/Region
4.3 Americas Non-animal Type Hard Capsules Sales Growth
4.4 APAC Non-animal Type Hard Capsules Sales Growth
4.5 Europe Non-animal Type Hard Capsules Sales Growth
4.6 Middle East & Africa Non-animal Type Hard Capsules Sales Growth
5 Americas
5.1 Americas Non-animal Type Hard Capsules Sales by Country
5.1.1 Americas Non-animal Type Hard Capsules Sales by Country (2017-2022)
5.1.2 Americas Non-animal Type Hard Capsules Revenue by Country (2017-2022)
5.2 Americas Non-animal Type Hard Capsules Sales by Type
5.3 Americas Non-animal Type Hard Capsules Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-animal Type Hard Capsules Sales by Region
6.1.1 APAC Non-animal Type Hard Capsules Sales by Region (2017-2022)
6.1.2 APAC Non-animal Type Hard Capsules Revenue by Region (2017-2022)
6.2 APAC Non-animal Type Hard Capsules Sales by Type
6.3 APAC Non-animal Type Hard Capsules Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Non-animal Type Hard Capsules by Country
7.1.1 Europe Non-animal Type Hard Capsules Sales by Country (2017-2022)
7.1.2 Europe Non-animal Type Hard Capsules Revenue by Country (2017-2022)
7.2 Europe Non-animal Type Hard Capsules Sales by Type
7.3 Europe Non-animal Type Hard Capsules Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Non-animal Type Hard Capsules by Country
8.1.1 Middle East & Africa Non-animal Type Hard Capsules Sales by Country (2017-2022)
8.1.2 Middle East & Africa Non-animal Type Hard Capsules Revenue by Country (2017-2022)
8.2 Middle East & Africa Non-animal Type Hard Capsules Sales by Type
8.3 Middle East & Africa Non-animal Type Hard Capsules Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-animal Type Hard Capsules
10.3 Manufacturing Process Analysis of Non-animal Type Hard Capsules
10.4 Industry Chain Structure of Non-animal Type Hard Capsules
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-animal Type Hard Capsules Distributors
11.3 Non-animal Type Hard Capsules Customer
12 World Forecast Review for Non-animal Type Hard Capsules by Geographic Region
12.1 Global Non-animal Type Hard Capsules Market Size Forecast by Region
12.1.1 Global Non-animal Type Hard Capsules Forecast by Region (2023-2028)
12.1.2 Global Non-animal Type Hard Capsules Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-animal Type Hard Capsules Forecast by Type
12.7 Global Non-animal Type Hard Capsules Forecast by Application
13 Key Players Analysis
13.1 Lonza
13.1.1 Lonza Company Information
13.1.2 Lonza Non-animal Type Hard Capsules Product Offered
13.1.3 Lonza Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Lonza Main Business Overview
13.1.5 Lonza Latest Developments
13.2 ACG Associated Capsules
13.2.1 ACG Associated Capsules Company Information
13.2.2 ACG Associated Capsules Non-animal Type Hard Capsules Product Offered
13.2.3 ACG Associated Capsules Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 ACG Associated Capsules Main Business Overview
13.2.5 ACG Associated Capsules Latest Developments
13.3 JC Biological Technology
13.3.1 JC Biological Technology Company Information
13.3.2 JC Biological Technology Non-animal Type Hard Capsules Product Offered
13.3.3 JC Biological Technology Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 JC Biological Technology Main Business Overview
13.3.5 JC Biological Technology Latest Developments
13.4 CapsCanada
13.4.1 CapsCanada Company Information
13.4.2 CapsCanada Non-animal Type Hard Capsules Product Offered
13.4.3 CapsCanada Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 CapsCanada Main Business Overview
13.4.5 CapsCanada Latest Developments
13.5 Medicaps
13.5.1 Medicaps Company Information
13.5.2 Medicaps Non-animal Type Hard Capsules Product Offered
13.5.3 Medicaps Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Medicaps Main Business Overview
13.5.5 Medicaps Latest Developments
13.6 Qualicaps (Mitsubishi Chemical)
13.6.1 Qualicaps (Mitsubishi Chemical) Company Information
13.6.2 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product Offered
13.6.3 Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Qualicaps (Mitsubishi Chemical) Main Business Overview
13.6.5 Qualicaps (Mitsubishi Chemical) Latest Developments
13.7 Patheon (Banner Pharmacaps)
13.7.1 Patheon (Banner Pharmacaps) Company Information
13.7.2 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product Offered
13.7.3 Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Patheon (Banner Pharmacaps) Main Business Overview
13.7.5 Patheon (Banner Pharmacaps) Latest Developments
13.8 Roxlor
13.8.1 Roxlor Company Information
13.8.2 Roxlor Non-animal Type Hard Capsules Product Offered
13.8.3 Roxlor Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Roxlor Main Business Overview
13.8.5 Roxlor Latest Developments
13.9 Sunil Healthcare
13.9.1 Sunil Healthcare Company Information
13.9.2 Sunil Healthcare Non-animal Type Hard Capsules Product Offered
13.9.3 Sunil Healthcare Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Sunil Healthcare Main Business Overview
13.9.5 Sunil Healthcare Latest Developments
13.10 Arab-Caps
13.10.1 Arab-Caps Company Information
13.10.2 Arab-Caps Non-animal Type Hard Capsules Product Offered
13.10.3 Arab-Caps Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Arab-Caps Main Business Overview
13.10.5 Arab-Caps Latest Developments
13.11 Jedco International Pharmaceutical
13.11.1 Jedco International Pharmaceutical Company Information
13.11.2 Jedco International Pharmaceutical Non-animal Type Hard Capsules Product Offered
13.11.3 Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Jedco International Pharmaceutical Main Business Overview
13.11.5 Jedco International Pharmaceutical Latest Developments
13.12 Pharco
13.12.1 Pharco Company Information
13.12.2 Pharco Non-animal Type Hard Capsules Product Offered
13.12.3 Pharco Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Pharco Main Business Overview
13.12.5 Pharco Latest Developments
13.13 ACPL
13.13.1 ACPL Company Information
13.13.2 ACPL Non-animal Type Hard Capsules Product Offered
13.13.3 ACPL Non-animal Type Hard Capsules Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 ACPL Main Business Overview
13.13.5 ACPL Latest Developments
14 Research Findings and Conclusion
Table 1. Non-animal Type Hard Capsules Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Non-animal Type Hard Capsules Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Type I
Table 4. Major Players of 00E
Table 5. Major Players of 0E
Table 6. Global Non-animal Type Hard Capsules Sales by Type (2017-2022) & (K Units)
Table 7. Global Non-animal Type Hard Capsules Sales Market Share by Type (2017-2022)
Table 8. Global Non-animal Type Hard Capsules Revenue by Type (2017-2022) & ($ million)
Table 9. Global Non-animal Type Hard Capsules Revenue Market Share by Type (2017-2022)
Table 10. Global Non-animal Type Hard Capsules Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Non-animal Type Hard Capsules Sales by Application (2017-2022) & (K Units)
Table 12. Global Non-animal Type Hard Capsules Sales Market Share by Application (2017-2022)
Table 13. Global Non-animal Type Hard Capsules Revenue by Application (2017-2022)
Table 14. Global Non-animal Type Hard Capsules Revenue Market Share by Application (2017-2022)
Table 15. Global Non-animal Type Hard Capsules Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Non-animal Type Hard Capsules Sales by Company (2020-2022) & (K Units)
Table 17. Global Non-animal Type Hard Capsules Sales Market Share by Company (2020-2022)
Table 18. Global Non-animal Type Hard Capsules Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Non-animal Type Hard Capsules Revenue Market Share by Company (2020-2022)
Table 20. Global Non-animal Type Hard Capsules Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Non-animal Type Hard Capsules Producing Area Distribution and Sales Area
Table 22. Players Non-animal Type Hard Capsules Products Offered
Table 23. Non-animal Type Hard Capsules Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Non-animal Type Hard Capsules Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Non-animal Type Hard Capsules Sales Market Share Geographic Region (2017-2022)
Table 28. Global Non-animal Type Hard Capsules Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Non-animal Type Hard Capsules Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Non-animal Type Hard Capsules Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Non-animal Type Hard Capsules Sales Market Share by Country/Region (2017-2022)
Table 32. Global Non-animal Type Hard Capsules Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Non-animal Type Hard Capsules Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Non-animal Type Hard Capsules Sales by Country (2017-2022) & (K Units)
Table 35. Americas Non-animal Type Hard Capsules Sales Market Share by Country (2017-2022)
Table 36. Americas Non-animal Type Hard Capsules Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Non-animal Type Hard Capsules Revenue Market Share by Country (2017-2022)
Table 38. Americas Non-animal Type Hard Capsules Sales by Type (2017-2022) & (K Units)
Table 39. Americas Non-animal Type Hard Capsules Sales Market Share by Type (2017-2022)
Table 40. Americas Non-animal Type Hard Capsules Sales by Application (2017-2022) & (K Units)
Table 41. Americas Non-animal Type Hard Capsules Sales Market Share by Application (2017-2022)
Table 42. APAC Non-animal Type Hard Capsules Sales by Region (2017-2022) & (K Units)
Table 43. APAC Non-animal Type Hard Capsules Sales Market Share by Region (2017-2022)
Table 44. APAC Non-animal Type Hard Capsules Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Non-animal Type Hard Capsules Revenue Market Share by Region (2017-2022)
Table 46. APAC Non-animal Type Hard Capsules Sales by Type (2017-2022) & (K Units)
Table 47. APAC Non-animal Type Hard Capsules Sales Market Share by Type (2017-2022)
Table 48. APAC Non-animal Type Hard Capsules Sales by Application (2017-2022) & (K Units)
Table 49. APAC Non-animal Type Hard Capsules Sales Market Share by Application (2017-2022)
Table 50. Europe Non-animal Type Hard Capsules Sales by Country (2017-2022) & (K Units)
Table 51. Europe Non-animal Type Hard Capsules Sales Market Share by Country (2017-2022)
Table 52. Europe Non-animal Type Hard Capsules Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Non-animal Type Hard Capsules Revenue Market Share by Country (2017-2022)
Table 54. Europe Non-animal Type Hard Capsules Sales by Type (2017-2022) & (K Units)
Table 55. Europe Non-animal Type Hard Capsules Sales Market Share by Type (2017-2022)
Table 56. Europe Non-animal Type Hard Capsules Sales by Application (2017-2022) & (K Units)
Table 57. Europe Non-animal Type Hard Capsules Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Non-animal Type Hard Capsules Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Non-animal Type Hard Capsules Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Non-animal Type Hard Capsules Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Non-animal Type Hard Capsules Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Non-animal Type Hard Capsules Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Non-animal Type Hard Capsules Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Non-animal Type Hard Capsules Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Non-animal Type Hard Capsules Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Non-animal Type Hard Capsules
Table 67. Key Market Challenges & Risks of Non-animal Type Hard Capsules
Table 68. Key Industry Trends of Non-animal Type Hard Capsules
Table 69. Non-animal Type Hard Capsules Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Non-animal Type Hard Capsules Distributors List
Table 72. Non-animal Type Hard Capsules Customer List
Table 73. Global Non-animal Type Hard Capsules Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Non-animal Type Hard Capsules Sales Market Forecast by Region
Table 75. Global Non-animal Type Hard Capsules Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Non-animal Type Hard Capsules Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Non-animal Type Hard Capsules Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Non-animal Type Hard Capsules Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Non-animal Type Hard Capsules Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Non-animal Type Hard Capsules Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Non-animal Type Hard Capsules Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Non-animal Type Hard Capsules Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Non-animal Type Hard Capsules Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Non-animal Type Hard Capsules Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Non-animal Type Hard Capsules Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Non-animal Type Hard Capsules Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Non-animal Type Hard Capsules Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Non-animal Type Hard Capsules Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Non-animal Type Hard Capsules Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Non-animal Type Hard Capsules Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Non-animal Type Hard Capsules Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Non-animal Type Hard Capsules Revenue Market Share Forecast by Application (2023-2028)
Table 93. Lonza Basic Information, Non-animal Type Hard Capsules Manufacturing Base, Sales Area and Its Competitors
Table 94. Lonza Non-animal Type Hard Capsules Product Offered
Table 95. Lonza Non-animal Type Hard Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. Lonza Main Business
Table 97. Lonza Latest Developments
Table 98. ACG Associated Capsules Basic Information, Non-animal Type Hard Capsules Manufacturing Base, Sales Area and Its Competitors
Table 99. ACG Associated Capsules Non-animal Type Hard Capsules Product Offered
Table 100. ACG Associated Capsules Non-animal Type Hard Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 101. ACG Associated Capsules Main Business
Table 102. ACG Associated Capsules Latest Developments
Table 103. JC Biological Technology Basic Information, Non-animal Type Hard Capsules Manufacturing Base, Sales Area and Its Competitors
Table 104. JC Biological Technology Non-animal Type Hard Capsules Product Offered
Table 105. JC Biological Technology Non-animal Type Hard Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 106. JC Biological Technology Main Business
Table 107. JC Biological Technology Latest Developments
Table 108. CapsCanada Basic Information, Non-animal Type Hard Capsules Manufacturing Base, Sales Area and Its Competitors
Table 109. CapsCanada Non-animal Type Hard Capsules Product Offered
Table 110. CapsCanada Non-animal Type Hard Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 111. CapsCanada Main Business
Table 112. CapsCanada Latest Developments
Table 113. Medicaps Basic Information, Non-animal Type Hard Capsules Manufacturing Base, Sales Area and Its Competitors
Table 114. Medicaps Non-animal Type Hard Capsules Product Offered
Table 115. Medicaps Non-animal Type Hard Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 116. Medicaps Main Business
Table 117. Medicaps Latest Developments
Table 118. Qualicaps (Mitsubishi Chemical) Basic Information, Non-animal Type Hard Capsules Manufacturing Base, Sales Area and Its Competitors
Table 119. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Product Offered
Table 120. Qualicaps (Mitsubishi Chemical) Non-animal Type Hard Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 121. Qualicaps (Mitsubishi Chemical) Main Business
Table 122. Qualicaps (Mitsubishi Chemical) Latest Developments
Table 123. Patheon (Banner Pharmacaps) Basic Information, Non-animal Type Hard Capsules Manufacturing Base, Sales Area and Its Competitors
Table 124. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Product Offered
Table 125. Patheon (Banner Pharmacaps) Non-animal Type Hard Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 126. Patheon (Banner Pharmacaps) Main Business
Table 127. Patheon (Banner Pharmacaps) Latest Developments
Table 128. Roxlor Basic Information, Non-animal Type Hard Capsules Manufacturing Base, Sales Area and Its Competitors
Table 129. Roxlor Non-animal Type Hard Capsules Product Offered
Table 130. Roxlor Non-animal Type Hard Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 131. Roxlor Main Business
Table 132. Roxlor Latest Developments
Table 133. Sunil Healthcare Basic Information, Non-animal Type Hard Capsules Manufacturing Base, Sales Area and Its Competitors
Table 134. Sunil Healthcare Non-animal Type Hard Capsules Product Offered
Table 135. Sunil Healthcare Non-animal Type Hard Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 136. Sunil Healthcare Main Business
Table 137. Sunil Healthcare Latest Developments
Table 138. Arab-Caps Basic Information, Non-animal Type Hard Capsules Manufacturing Base, Sales Area and Its Competitors
Table 139. Arab-Caps Non-animal Type Hard Capsules Product Offered
Table 140. Arab-Caps Non-animal Type Hard Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 141. Arab-Caps Main Business
Table 142. Arab-Caps Latest Developments
Table 143. Jedco International Pharmaceutical Basic Information, Non-animal Type Hard Capsules Manufacturing Base, Sales Area and Its Competitors
Table 144. Jedco International Pharmaceutical Non-animal Type Hard Capsules Product Offered
Table 145. Jedco International Pharmaceutical Non-animal Type Hard Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 146. Jedco International Pharmaceutical Main Business
Table 147. Jedco International Pharmaceutical Latest Developments
Table 148. Pharco Basic Information, Non-animal Type Hard Capsules Manufacturing Base, Sales Area and Its Competitors
Table 149. Pharco Non-animal Type Hard Capsules Product Offered
Table 150. Pharco Non-animal Type Hard Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 151. Pharco Main Business
Table 152. Pharco Latest Developments
Table 153. ACPL Basic Information, Non-animal Type Hard Capsules Manufacturing Base, Sales Area and Its Competitors
Table 154. ACPL Non-animal Type Hard Capsules Product Offered
Table 155. ACPL Non-animal Type Hard Capsules Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 156. ACPL Main Business
Table 157. ACPL Latest Developments
List of Figures
Figure 1. Picture of Non-animal Type Hard Capsules
Figure 2. Non-animal Type Hard Capsules Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-animal Type Hard Capsules Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Non-animal Type Hard Capsules Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Non-animal Type Hard Capsules Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Type I
Figure 10. Product Picture of 00E
Figure 11. Product Picture of 0E
Figure 12. Global Non-animal Type Hard Capsules Sales Market Share by Type in 2021
Figure 13. Global Non-animal Type Hard Capsules Revenue Market Share by Type (2017-2022)
Figure 14. Non-animal Type Hard Capsules Consumed in Pharmaceutical
Figure 15. Global Non-animal Type Hard Capsules Market: Pharmaceutical (2017-2022) & (K Units)
Figure 16. Non-animal Type Hard Capsules Consumed in Nutraceutical
Figure 17. Global Non-animal Type Hard Capsules Market: Nutraceutical (2017-2022) & (K Units)
Figure 18. Non-animal Type Hard Capsules Consumed in Cosmetics
Figure 19. Global Non-animal Type Hard Capsules Market: Cosmetics (2017-2022) & (K Units)
Figure 20. Global Non-animal Type Hard Capsules Sales Market Share by Application (2017-2022)
Figure 21. Global Non-animal Type Hard Capsules Revenue Market Share by Application in 2021
Figure 22. Non-animal Type Hard Capsules Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Non-animal Type Hard Capsules Revenue Market Share by Company in 2021
Figure 24. Global Non-animal Type Hard Capsules Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Non-animal Type Hard Capsules Revenue Market Share by Geographic Region in 2021
Figure 26. Global Non-animal Type Hard Capsules Sales Market Share by Region (2017-2022)
Figure 27. Global Non-animal Type Hard Capsules Revenue Market Share by Country/Region in 2021
Figure 28. Americas Non-animal Type Hard Capsules Sales 2017-2022 (K Units)
Figure 29. Americas Non-animal Type Hard Capsules Revenue 2017-2022 ($ Millions)
Figure 30. APAC Non-animal Type Hard Capsules Sales 2017-2022 (K Units)
Figure 31. APAC Non-animal Type Hard Capsules Revenue 2017-2022 ($ Millions)
Figure 32. Europe Non-animal Type Hard Capsules Sales 2017-2022 (K Units)
Figure 33. Europe Non-animal Type Hard Capsules Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Non-animal Type Hard Capsules Sales 2017-2022 (K Units)
Figure 35. Middle East & Africa Non-animal Type Hard Capsules Revenue 2017-2022 ($ Millions)
Figure 36. Americas Non-animal Type Hard Capsules Sales Market Share by Country in 2021
Figure 37. Americas Non-animal Type Hard Capsules Revenue Market Share by Country in 2021
Figure 38. United States Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Non-animal Type Hard Capsules Sales Market Share by Region in 2021
Figure 43. APAC Non-animal Type Hard Capsules Revenue Market Share by Regions in 2021
Figure 44. China Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Non-animal Type Hard Capsules Sales Market Share by Country in 2021
Figure 51. Europe Non-animal Type Hard Capsules Revenue Market Share by Country in 2021
Figure 52. Germany Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Non-animal Type Hard Capsules Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Non-animal Type Hard Capsules Revenue Market Share by Country in 2021
Figure 59. Egypt Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Non-animal Type Hard Capsules Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Non-animal Type Hard Capsules in 2021
Figure 65. Manufacturing Process Analysis of Non-animal Type Hard Capsules
Figure 66. Industry Chain Structure of Non-animal Type Hard Capsules
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...